Alcon Inc. (ALC)

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
United States Revenue	4.75B	4.66B	4.51B
United States Revenue Growth	1.95%	3.24%	4.61%
International Revenue	5.81B	5.66B	5.33B
International Revenue Growth	2.53%	6.33%	5.28%
Total Other Revenue	81.00M	82.00M	75.00M
Total Other Revenue Growth	-1.22%	9.33%	-11.77%
Revenue (Total)	10.63B	10.40B	9.91B
Revenue (Total) Growth	2.24%	4.94%	4.82%

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Implantables Revenue	1.80B	1.78B	1.78B
Implantables Revenue Growth	1.01%	0.39%	4.23%
Consumables Revenue	3.09B	3.03B	2.86B
Consumables Revenue Growth	1.88%	5.84%	5.22%
Equipment/Other Revenue	995.00M	941.00M	886.00M
Equipment/Other Revenue Growth	5.74%	6.21%	-0.67%
Total Surgical Revenue	5.88B	5.75B	5.52B
Total Surgical Revenue Growth	2.24%	4.15%	3.91%
Contact Lenses Revenue	2.82B	2.77B	2.61B
Contact Lenses Revenue Growth	1.80%	6.17%	8.71%
Ocular Health Revenue	1.85B	1.80B	1.71B
Ocular Health Revenue Growth	3.06%	5.46%	2.96%
Total Vision Care Revenue	4.67B	4.57B	4.31B
Total Vision Care Revenue Growth	2.30%	5.89%	6.36%
Total Other Revenue	81.00M	82.00M	75.00M
Total Other Revenue Growth	-1.22%	9.33%	-11.77%
Revenue (Total)	10.63B	10.40B	9.91B
Revenue (Total) Growth	2.24%	4.94%	4.82%

EBIT

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Surgical Segment Contribution	1.49B	1.46B	1.47B
Surgical Segment Contribution Growth	2.12%	-0.48%	0.89%
Vision Care Segment Contribution	994.00M	981.00M	962.00M
Vision Care Segment Contribution Growth	1.32%	1.98%	23.81%
Other Segment Contribution	-1.30B	-1.08B	-1.02B
Operating Income (Total)	1.18B	1.36B	1.41B
Operating Income (Total) Growth	-12.94%	-3.75%	36.00%

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Surgical Constant Currency Sales Growth	4.00%	5.00%
Vision Care Constant Currency Sales Growth	5.00%	7.00%
Total Constant Currency Sales Growth	4.00%	6.00%

Data Source: Fiscal.ai Last updated: May 6, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 4, 2026

Data Sources Report a data error